Cross Town News
Cross Town News India Follow Editor Rahil Gupta on   Twitter   Instagram

Serum Institute to start phase 3 trials of COVID-19 vaccine Covovax by mid-May


Cinosural International An Elementry School Jammu

New Delhi, May 04: Serum Institute of India is likely to start phase 3 trials of COVID-19 vaccine Covovax, which it is making in partnership with American company Novavax, by mid-may.

The Drugs Controller General of India has provided its approval to go for the next phase trials.

Covovax is the second vaccine candidate after Covishield that SII is manufacturing.

Dr Abhijit Kadam, Scientist C, coordinating principal investigator from ICMR-National AIDS Research Institute of the trial, said that tentatively phase-3 should start by mid-May. 

 


   Popular News

Top